Miromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference
EDEN PRAIRIE, Minn., Nov. 21, 2022 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ:MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that the Company will participate in the Piper Sandler 34th Annual Healthcare Conference on December 1st, 2022.
Related news for (MIRO)
- United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger
- Miromatrix to Report First Quarter 2023 Financial Results
- Miromatrix to Report First Quarter 2023 Financial Results
- CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation
- CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation